Alter awarded NIH grant for innovative HIV vaccine approach

Date: August 21, 2012 By:

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded 14 grants totaling $7.8 million in first-year funding for basic research to identify new approaches for designing a safe and effective HIV vaccine. The grants were awarded under the Innovation for HIV Vaccine Discovery (IHVD) initiative, which is expected to receive up to $34.8 million over the next four years.


“Recent discoveries about the basic biology of HIV and how the virus adapts to its host have provided useful information and new opportunities to guide vaccine development,” said NIAID Director Anthony S. Fauci, M.D. “These grants are designed to build on that information and stimulate discovery of new ways to design a robust vaccine that prevents acquisition and establishment of latent infection.”


Ragon Institute Investigator Dr. Galit Alter was one of 14 recipients of this NIAID grant.


View full list of awardees  (via NIAID)

More News

Ragon Partnering with Bright Horizons to Offer Child Care Center at New Headquarters

The Ragon Institute is delighted to announce the upcoming launch of the Ragon Child Care Center at our new building at 600 Main Street. Operated by our renowned partners at Bright Horizons, the Ragon Child Care Center will offer top-notch early childhood education and care right at the heart of our community.

Evavold Presents at RCCHU Seminar

On July 9, Ragon faculty member and Early Independence Fellow Charles Evavold, PhD, participated in a special seminar as part of the Science Seminar Series @RCCHU titled “Synthetic Biology Strategies for Human Health: From Yeasts to Immune Cells.”

“A Wonderful Opportunity” – An Interview with Ragon Postdoc and Ramón Areces Foundation Research Fellow Gema González Rubio

González Rubio discusses the circumstances that brought her to the Ragon and how she hopes to grow from it